- Home
- BBCP vs RGNX Comparison
BBCP vs RGNX Comparison
Compare BBCP & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBCP
- RGNX
- Stock Information
- Founded
- BBCP 1983
- RGNX 2008
- Country
- BBCP United States
- RGNX United States
- Employees
- BBCP N/A
- RGNX N/A
- Industry
- BBCP Engineering & Construction
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBCP Consumer Discretionary
- RGNX Health Care
- Exchange
- BBCP Nasdaq
- RGNX Nasdaq
- Market Cap
- BBCP 360.0M
- RGNX 424.8M
- IPO Year
- BBCP 2017
- RGNX 2015
- Fundamental
- Price
- BBCP $7.25
- RGNX $8.93
- Analyst Decision
- BBCP Buy
- RGNX Strong Buy
- Analyst Count
- BBCP 2
- RGNX 8
- Target Price
- BBCP $7.00
- RGNX $28.50
- AVG Volume (30 Days)
- BBCP 88.1K
- RGNX 674.4K
- Earning Date
- BBCP 09-03-2025
- RGNX 08-07-2025
- Dividend Yield
- BBCP N/A
- RGNX N/A
- EPS Growth
- BBCP N/A
- RGNX N/A
- EPS
- BBCP 0.23
- RGNX N/A
- Revenue
- BBCP $401,503,000.00
- RGNX $155,782,000.00
- Revenue This Year
- BBCP N/A
- RGNX $327.08
- Revenue Next Year
- BBCP $4.28
- RGNX N/A
- P/E Ratio
- BBCP $31.11
- RGNX N/A
- Revenue Growth
- BBCP N/A
- RGNX 74.95
- 52 Week Low
- BBCP $4.78
- RGNX $5.04
- 52 Week High
- BBCP $9.68
- RGNX $13.48
- Technical
- Relative Strength Index (RSI)
- BBCP 61.20
- RGNX 55.95
- Support Level
- BBCP $6.61
- RGNX $7.35
- Resistance Level
- BBCP $7.23
- RGNX $8.48
- Average True Range (ATR)
- BBCP 0.26
- RGNX 0.51
- MACD
- BBCP 0.01
- RGNX 0.00
- Stochastic Oscillator
- BBCP 91.43
- RGNX 80.20
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.